Parameters critical for the effector mechanism of anti-CD20 antibodies revisited

被引：1
|
作者：
Stasilojc, Grzegorz [1 ]
Felberg, Anna [1 ]
Okroj, Marcin [1 ]
机构：
[1] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 180卷 / 06期
关键词：
anti-CD20; antibodies; hybridoma formation; MONOCLONAL-ANTIBODIES; CD20; RITUXIMAB; EFFICACY; IMMUNOTHERAPY; CYTOTOXICITY; MALIGNANCIES; COMPLEMENT; RESISTANCE; THERAPY;
D O I：
10.1111/bjh.15130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [1] Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies
    Okroj, Marcin
    Osterborg, Anders
    Blom, Anna M.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (06) : 632 - 639
  • [2] Anti-CD20 antibodies with increased antigen binding affinity and enhanced effector function
    Lowman, H.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 273 - 273
  • [3] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [4] Clinical applications of anti-CD20 antibodies
    Gopal, AK
    Press, OW
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (05): : 445 - 450
  • [5] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [6] Anti-CD20 monoclonal antibodies: reviewing a revolution
    Casan, J. M. L.
    Wong, J.
    Northcott, M. J.
    Opat, S.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2820 - 2841
  • [7] Mechanisms of killing by anti-CD20 monoclonal antibodies
    Glennie, Martin J.
    French, Ruth R.
    Cragg, Mark S.
    Taylor, Ronald P.
    [J]. MOLECULAR IMMUNOLOGY, 2007, 44 (16) : 3823 - 3837
  • [8] Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies
    Taylor, Ronald P.
    Lindorfer, Margaret A.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (04) : 444 - 449
  • [9] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    [J]. CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
  • [10] The mechanism of action of anti-CD20 monoclonal antibodies used in the treatment of multiple sclerosis
    Mycko, Marcin P.
    [J]. AKTUALNOSCI NEUROLOGICZNE, 2023, 23 (03): : 72 - 78
12345